This episode unpacks the fascinating world of Quality by Design (QbD) in drug development, guided by ICH Q8 and Q11 principles. We explore how QbD ensures quality is built into every stage of a drug's lifecycle, from identifying critical quality attributes (CQAs) to defining flexible design spaces for manufacturing.

Discover the shift from reactive to proactive approaches in pharmaceutical production, leveraging tools like risk assessment, process modeling, and statistical analysis to optimize quality and minimize variability. We also dive into how QbD benefits manufacturers by reducing waste and improving efficiency, while ultimately delivering safer and more effective medications to patients.

Join us as we break down the science, innovation, and real-world impact of QbD, showcasing how this approach is revolutionizing the pharmaceutical industry and driving continuous improvement.